EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy

Youyou Li, Jing Liu, Yimei Chen, Ralph R Weichselbaum, Wenbin Lin iD

Advanced Science · 2024-06 · 11 (23)

DOI: 10.1002/advs.202310309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 13.03.2024. Verfasst von Youyou Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, IL, 60637, USA. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Copper, Nanoparticles. Die Arbeit wurde bisher 125-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent discovery of copper‐mediated and mitochondrion‐dependent cuproptosis has aroused strong interest in harnessing this novel mechanism of cell death for cancer therapy. Here the design of a core‐shell nanoparticle, CuP/Er, for the co‐delivery of copper (Cu) and erastin (Er) to cancer cells for synergistic cuproptosis and ferroptosis is reported. The anti‐Warburg effect of Er sensitizes tumor cells to Cu‐mediated cuproptosis, leading to irreparable mitochondrial damage by depleting glutathione and enhancing lipid peroxidation. CuP/Er induces strong immunogenic cell death, enhances antigen presentation, and upregulates programmed death‐ligand 1 expression. Consequently, CuP/Er promotes proliferation and infiltration of T cells, and when combined with immune checkpoint blockade, effectively reinvigorates T cells to mediate the regression of murine colon adenocarcinoma and triple‐negative breast cancer and prevent tumor metastasis. This study suggests a unique opportunity to synergize cuproptosis and ferroptosis with combination therapy nanoparticles to elicit strong antitumor effects and potentiate current cancer immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisImmunotherapyCopperNanoparticlesAnimalsMiceDisease Models, AnimalHumansCell Line, TumorFemaleTriple Negative Breast NeoplasmsPiperazines

Stichwörter der Autor:innen

cuproptosisferroptosisimmunotherapynanoparticles

Substanzen

CoppererastinPiperazines

Autor:innen und Institutionen

  • Department of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
  • Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, IL, 60637, USA.

ORCID-Profile: Wenbin Lin

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Li, Y., Liu, J., Chen, Y., Weichselbaum, R. R., & Lin, W. (2024). Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Advanced Science, 11(23). https://doi.org/10.1002/advs.202310309

Vancouver

Li Y, Liu J, Chen Y, Weichselbaum RR, Lin W. Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy. Advanced Science. 2024;11(23). doi:10.1002/advs.202310309

BibTeX
@article{Li2024,
  author = {Li, Youyou and Liu, Jing and Chen, Yimei and Weichselbaum, Ralph R and Lin, Wenbin},
  title = {Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {23},
  doi = {10.1002/advs.202310309}
}
Kostenlos starten →